Full Text View
Tabular View
No Study Results Posted
Related Studies
The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed
This study has been completed.
Study NCT00534677   Information provided by Aga Khan University
First Received: September 24, 2007   Last Updated: December 4, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Portal Hypertension
Cirrhosis
Hematemesis
Melena
Additional conditions recognized in this trial
Fibrosis
Hypertension
Hypertension, Portal
Liver Cirrhosis
More general conditions related to this trial
Cardiovascular Diseases
Digestive System Diseases
Gastrointestinal Diseases
Gastrointestinal Hemorrhage
Hemorrhage
Liver Diseases
Pathologic Processes
Signs and Symptoms
Signs and Symptoms, Digestive
Vascular Diseases
Vomiting
Interventions listed in this trial
Terlipressin
Octreotide
Additional drug interventions recognized in this trial
Lysine Vasopressin
More general drug interventions related to this trial
Antidiuretic Agents
Antihypertensive Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Cardiovascular Agents
Coagulants
Gastrointestinal Agents
Hematologic Agents
Hemostatics
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
Aga Khan University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services